SIGN UP
LOG IN
G
GMED
Globus Med Inc
57.31
0.71+1.25%After Hours: 56.84 -0.47 -0.82%19:26 07/09 EDT
OPEN/PREV CLOSE56.77/56.60
TODAY RANGE55.51-57.35
VOL2.16M
MARKET CAP7.76B
52 WEEK RANGE54.48-94.93
AVG VOL (3M)1.51M
% TURNOVER1.59%
TURNOVER--
P/E (TTM)42.86
% RANGE3.25%
EPS(TTM)1.337
P/E(FORWARD)22.30
P/B1.898
BVPS30.20
DIVIDEND--
P/S3.126
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP6.43B
SHARES OUTSTANDING135.38M
NEXT EARNINGS08/04-08/08
FREE FLOAT112.17M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·6d ago
Globus Medical: Obtaining My Backing Again
NASDAQ·07/01 12:10
Can ISRG Maintain Robotics Edge Amid Rising Rivalry & Budget Strain?
Seeking Alpha·06/30 14:39
Alphatec: Continued Growth, Narrowing Losses
Seeking Alpha·06/29 17:17
Thrivent Small Cap Growth Fund Q1 2025 Commentary
Benzinga·06/25 19:00
Price Over Earnings Overview: Globus Medical
TipRanks·06/24 11:36
Canaccord Genuity Keeps Their Buy Rating on Globus Medical (GMED)
TipRanks·06/20 08:35
Globus Medical (GMED) Receives a Buy from Barclays
Benzinga·06/16 18:00
Is the Market Bullish or Bearish on Globus Medical?
Simply Wall St·06/15 13:17
Is Globus Medical, Inc.'s (NYSE:GMED) Recent Price Movement Underpinned By Its Weak Fundamentals?
NASDAQ·06/12 11:02
How The Parts Add Up: IWS Headed For $146
TipRanks·06/10 11:40
Barclays bullish on Globus Medical, sees share upside to $103
NASDAQ·06/05 13:37
Intuitive Surgical's da Vinci 5: Gaining Precision, Power and Potential
Benzinga·05/28 16:00
A Look Into Globus Medical Inc's Price Over Earnings
TipRanks·05/28 15:25
Needham medtech & diagnostics analyst holds analyst/industry conference call
TipRanks·05/27 13:45
AMD, Block upgraded: Wall Street’s top analyst calls
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.